A lawsuit claims that the Biomet Magnum M2a hip replacement is defective, causing injury to patients.

Plaintiff Monica T. claims that in 2007, she underwent a hip replacement surgery on her right hip, and was fitted with a Biomet M2aMagnum metal-on-metal prosthetic hip. According to the plaintiff, defects in the implant’s materials and design caused the hip implant to fail, leading to injury and requiring revision surgery.

According to the Biomet Magnum M2a implant lawsuit, the implant fails by loosening from the bone in which it is installs. In other cases, the implant’s component metals, cobalt and chromium, wear and corrode from the implant from numerous parts of the implant. These metal fragments then allegedly enter the body, causing infection, prompting the body to reject the implant, and sometimes causing soft tissue and bone death around the implant.

Symptoms of the alleged Biomet Magnum M2a defects allegedly include:

• pain
• looseness of joint
• hip dislocation
• squeaking and popping sounds
• fluid accumulation
• bone death
• soft tissue death
• infection

According to Monica, her Biomet Magnum M2a failed as a result of the product’s defects, “causing severe loosening of the device and/or toxic levels of cobalt and chromium, tissue and bone destruction, and the need … to undergo a complex and risky surgery to remove and replace  the defective implant.” She states that she had the revision surgery in April 2016.

According to the defective Biomet implant lawsuit, many consumers suffer such extensive injury from the implant that they require a revision surgery. The lawsuit claims that studies have shown that a revision surgery carries with it even more risks than an initial hip replacement surgery. Allegedly, the risk of infection, hip dislocation, pulmonary embolism, and other injuries are significantly higher after revision surgery than after initial surgery.

Monica claims that Biomet, the implant’s makers, knew that the product was defective and prone to failure, but the company did not disclose this information to patients or physicians. Allegedly, her physician installed the Biomet Magnum M2a based on information from manufacturers that the implant was safe and effective. She alleges that this information was a gross misrepresentation of reality.

According to the Biomet hip replacement lawsuit, Biomet knew that the Magnum M2a was possibly defective as early as 2004, when consumer complaints came in stating that the device was defective and had to be replaced. Allegedly, Biomet received hundreds of comparable complaints in the years after.

The Biomet lawsuit claims that over 350 reports have been made that associate the Biomet Magnum M2a hip system with defects and injury. Monica alleges that the company continued to sell the product and market it as safe and effective, disregarding the extensive harm done to patients.

Monica seeks damages for physical injury, financial injury to compensate for work missed and wages lost, and for emotional injury for the trauma of undergoing surgery and experiencing possibly permanent injury.

The Biomet Magnum M2a Failure Lawsuit is Case No. 3:18-cv-00174-RLM-MGG, in the U.S. District for the Northern District of Indiana, South Bend Division.